Literature DB >> 12664214

Laparoscopic approach for human islet transplantation into a defined liver segment in type-1 diabetic patients.

Babak Movahedi1, Bart Keymeulen, Mary-Helen Lauwers, Eva Goes, Nadine Cools, Georges Delvaux.   

Abstract

Intra-portal islet transplantation is usually performed by cannulation of a mesenteric vein during laparotomy or through percutaneous trans-hepatic cannulation of a portal branch. In this study, we describe a new laparoscopic technique for intra-portal islet transplantation in a defined liver segment, as an alternative to the current procedures. Eighteen type-1 diabetic patients underwent laparoscopic re-permeabilisation of the umbilical vein, followed by catheterization of the left branch of the portal vein. The catheter was guided under fluoroscopic control into a chosen liver segment. It was then secured to the skin or connected to an implantable venous access device. Thereafter, the islet preparation was slowly injected. There was no rise in portal pressure. The median duration of the procedure was 85 min. The procedure was successful in 17 of 18 cases. There were no surgical complications. We conclude that this laparoscopic procedure is a feasible, convenient, and safe alternative method of islet transplantation. Moreover, it allows multiple deliveries of islets into the same liver segment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12664214     DOI: 10.1007/s00147-002-0517-7

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

1.  Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft.

Authors:  Bart Keymeulen; Pieter Gillard; Chantal Mathieu; Babak Movahedi; Geert Maleux; Georges Delvaux; Dirk Ysebaert; Bart Roep; Evy Vandemeulebroucke; Miriam Marichal; Peter In 't Veld; Marika Bogdani; Christel Hendrieckx; Frans Gorus; Zhidong Ling; Jon van Rood; Daniel Pipeleers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

2.  Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.

Authors:  Zhidong Ling; Pieter De Pauw; Daniel Jacobs-Tulleneers-Thevissen; Rui Mao; Pieter Gillard; Christiane S Hampe; Geert A Martens; Peter In't Veld; Åke Lernmark; Bart Keymeulen; Frans Gorus; Daniel Pipeleers
Journal:  J Clin Endocrinol Metab       Date:  2015-03-27       Impact factor: 5.958

3.  Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.

Authors:  Morihito Takita; Shinichi Matsumoto; Masayuki Shimoda; Daisuke Chujo; Takeshi Itoh; Jeffrey A Sorelle; Kerri Purcell; Nicholas Onaca; Bashoo Naziruddin; Marlon F Levy
Journal:  Clin Transplant       Date:  2012 Sep-Oct       Impact factor: 2.863

4.  Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

Authors:  D L Roelen; V A L Huurman; R Hilbrands; P Gillard; G Duinkerken; P W M van der Meer-Prins; M F J Versteeg-van der Voort Maarschalk; C Mathieu; B Keymeulen; D G Pipeleers; B O Roep; F H J Claas
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

5.  Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D.

Authors:  Sarah Roels; Olivier R Costa; Sarah A Tersey; Geert Stangé; Dieter De Smet; Eric V Balti; Pieter Gillard; Bart Keymeulen; Zhidong Ling; Daniel G Pipeleers; Frans K Gorus; Raghavendra G Mirmira; Geert A Martens
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

6.  A preclinical evaluation of alternative site for islet allotransplantation.

Authors:  Chengshi Wang; Xiaojiong Du; Sirong He; Yujia Yuan; Pengfei Han; Dan Wang; Younan Chen; Jingping Liu; Bole Tian; Guang Yang; Shounan Yi; Fabao Gao; Zhihui Zhong; Hongxia Li; Jingqiu Cheng; Yanrong Lu
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

7.  Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients.

Authors:  Robert Hilbrands; Volkert A L Huurman; Pieter Gillard; Jurjen H L Velthuis; Marc De Waele; Chantal Mathieu; Leonard Kaufman; Miriam Pipeleers-Marichal; Zhidong Ling; Babak Movahedi; Daniel Jacobs-Tulleneers-Thevissen; Diethard Monbaliu; Dirk Ysebaert; Frans K Gorus; Bart O Roep; Daniel G Pipeleers; Bart Keymeulen
Journal:  Diabetes       Date:  2009-07-14       Impact factor: 9.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.